These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
248 related articles for article (PubMed ID: 38712559)
21. In vitro activity of novel in silico-developed antimicrobial peptides against a panel of bacterial pathogens. Romani AA; Baroni MC; Taddei S; Ghidini F; Sansoni P; Cavirani S; Cabassi CS J Pept Sci; 2013 Sep; 19(9):554-65. PubMed ID: 23893489 [TBL] [Abstract][Full Text] [Related]
22. Anisaxins, helical antimicrobial peptides from marine parasites, kill resistant bacteria by lipid extraction and membrane disruption. Rončević T; Gerdol M; Mardirossian M; Maleš M; Cvjetan S; Benincasa M; Maravić A; Gajski G; Krce L; Aviani I; Hrabar J; Trumbić Ž; Derks M; Pallavicini A; Weingarth M; Zoranić L; Tossi A; Mladineo I Acta Biomater; 2022 Jul; 146():131-144. PubMed ID: 35470073 [TBL] [Abstract][Full Text] [Related]
23. How do cyclic antibiotics with activity against Gram-negative bacteria permeate membranes? A machine learning informed experimental study. Lee MW; de Anda J; Kroll C; Bieniossek C; Bradley K; Amrein KE; Wong GCL Biochim Biophys Acta Biomembr; 2020 Aug; 1862(8):183302. PubMed ID: 32311341 [TBL] [Abstract][Full Text] [Related]
24. Design SMAP29-LysPA26 as a Highly Efficient Artilysin against Pseudomonas aeruginosa with Bactericidal and Antibiofilm Activity. Wang T; Zheng Y; Dai J; Zhou J; Yu R; Zhang C Microbiol Spectr; 2021 Dec; 9(3):e0054621. PubMed ID: 34878337 [TBL] [Abstract][Full Text] [Related]
26. Novel antimicrobial peptides based on Protegrin-1: In silico and in vitro assessments. Hosseini Goki N; Saberi MR; Amin M; Fazly Bazzaz BS; Khameneh B Microb Pathog; 2024 Nov; 196():106931. PubMed ID: 39288825 [TBL] [Abstract][Full Text] [Related]
27. Comparative Evaluation of the Antimicrobial Activity of Different Antimicrobial Peptides against a Range of Pathogenic Bacteria. Ebbensgaard A; Mordhorst H; Overgaard MT; Nielsen CG; Aarestrup FM; Hansen EB PLoS One; 2015; 10(12):e0144611. PubMed ID: 26656394 [TBL] [Abstract][Full Text] [Related]
28. Effects and mechanisms of the secondary structure on the antimicrobial activity and specificity of antimicrobial peptides. Mai XT; Huang J; Tan J; Huang Y; Chen Y J Pept Sci; 2015 Jul; 21(7):561-8. PubMed ID: 25826179 [TBL] [Abstract][Full Text] [Related]
30. Effects of lysine-to-arginine substitution on antimicrobial activity of cationic stapled heptapeptides. Luong HX; Kim DH; Lee BJ; Kim YW Arch Pharm Res; 2018 Nov; 41(11):1092-1097. PubMed ID: 30361948 [TBL] [Abstract][Full Text] [Related]
31. In Silico and In Vitro Structure-Activity Relationship of Mastoparan and Its Analogs. Rungsa P; Peigneur S; Jangpromma N; Klaynongsruang S; Tytgat J; Daduang S Molecules; 2022 Jan; 27(2):. PubMed ID: 35056876 [TBL] [Abstract][Full Text] [Related]
32. Antimicrobial Peptides: Mechanisms of Action and Resistance. Bechinger B; Gorr SU J Dent Res; 2017 Mar; 96(3):254-260. PubMed ID: 27872334 [TBL] [Abstract][Full Text] [Related]
33. NMR Structures and Interactions of Antimicrobial Peptides with Lipopolysaccharide: Connecting Structures to Functions. Bhattacharjya S Curr Top Med Chem; 2016; 16(1):4-15. PubMed ID: 26139110 [TBL] [Abstract][Full Text] [Related]
34. Optimized Charge/Hydrophobicity Balance of Antimicrobial Peptides Against Polymicrobial Abdominal Infections. Du K; Yang ZR; Qin H; Ma T; Tang J; Xia J; Zhou Z; Jiang H; Zhu J Macromol Biosci; 2024 May; 24(5):e2300451. PubMed ID: 37997560 [TBL] [Abstract][Full Text] [Related]
35. Broad-spectrum activity of membranolytic cationic macrocyclic peptides against multi-drug resistant bacteria and fungi. Lohan S; Konshina AG; Tiwari RK; Efremov RG; Maslennikov I; Parang K Eur J Pharm Sci; 2024 Jun; 197():106776. PubMed ID: 38663759 [TBL] [Abstract][Full Text] [Related]
36. Antimicrobial properties of membrane-active dodecapeptides derived from MSI-78. Monteiro C; Fernandes M; Pinheiro M; Maia S; Seabra CL; Ferreira-da-Silva F; Costa F; Reis S; Gomes P; Martins MC Biochim Biophys Acta; 2015 May; 1848(5):1139-46. PubMed ID: 25680229 [TBL] [Abstract][Full Text] [Related]
37. Dissecting the Therapeutic Potency of Antimicrobial Peptides Against Microbial Biofilms. Gupta P; Mishra P; Prasad R; Poluri KM Curr Protein Pept Sci; 2021 Oct; 22(4):336-360. PubMed ID: 33749561 [TBL] [Abstract][Full Text] [Related]
38. Recent Advances in Amphipathic Peptidomimetics as Antimicrobial Agents to Combat Drug Resistance. Su M; Su Y Molecules; 2024 May; 29(11):. PubMed ID: 38893366 [TBL] [Abstract][Full Text] [Related]